MedCity News April 9, 2024
Alexandra Moens

Leaders need a framework to identify, understand, effectively address diversity gaps, and measure improvement across the continuum of care. A data-driven approach can provide valuable insights into demographic trends, disparities in healthcare access and outcomes, and the underlying factors contributing to these discrepancies.

Disparities in diversity and inclusion continue to permeate every aspect of healthcare. Despite guidance from the FDA, a significant portion of the population remains underrepresented within the healthcare continuum.

In the U.S., stark statistics reveal the extent of these imbalances. Only about 36% of active physicians are female, with even fewer identifying as non-White. While Black and Hispanic Americans comprise a considerable portion of the population, their representation among healthcare practitioners is disproportionately low. Moreover, clinical trials—the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Equity/SDOH, Healthcare System, Patient / Consumer, Trends
When Medical A.I. is Lifesaving
STAT+: Doctors Without Borders challenges pharma by releasing costs for a key clinical trial
Systems thinking: A new paradigm for clinical trial design and operations
Duchenne Muscular Dystrophy: the global clinical trials landscape 2024
STAT+: New, serious safety risk related to MorphoSys’ cancer drug complicates, potentially threatens, Novartis acquisition

Share This Article